BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
BRAF
,
G-protein-coupled receptor binding
,
HIV infection
,
Prostate
,
Vitamin E
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
NHL repeat
(biogroup)
Summary
General Info
Body Atlas
Most Correlated Tissues
Cervix
Plasma cell of spleen
Monocyte of peripheral blood
Testes
Aorta
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Microbial culture finding
Pyloric ulcer
Perforation of tympanic membrane
Injury of external ear
Poisoning by drug AND/OR medicinal substance
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
JM 3100
ferrocene
Argon
glycidol
Secobarbital
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
CCDC170
UBB
BPHL
NUP85
ACTL6A
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Lymph nodes from induced experimental autoimmune encephalomyelitis (EAE) mice
Breast epithelial D492 line with epithelial mesenchymal transition (EMT) after endothelial coculture
Molecular phenotyping of miRNA expression of the idiopathic interstitial pneumonias
Hemin treatment, GATA1, EKLF or NF-E2 over-expressing and knocking-down in K562 cells
Colorectal cancers subtypes miRNA profiles
Explore Curated Studies Results
Literature
Most Relevant Literature
There were no matches for NHL repeat
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Safety Study of NHL With 90Y-hLL2 IgG
Study of Veltuzumab and 90Y-Epratuzumab in Relapsed/Refractory, Aggressive NHL
BAFFR-targeting CAR T Cells for Patients With Relapsed or Refractory B-NHL
Study of Chidamide as a Single-agent Treatment for Patients With Relapse or Refractory B-NHL
Study of CD30 CAR for Relapsed/Refractory CD30+ HL and CD30+ NHL
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ